Cartesian Therapeutics to Participate in Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Feb 18, 2025
FREDERICK, Md., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapies for autoimmune diseases, today announced that its management expects to participate in the following investor conferences in February and March:
Read more at globenewswire.com
